No headlines found.
Business Wire (Wed, 7-Jan 8:00 AM ET)
Business Wire (Wed, 3-Dec 8:00 AM ET)
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
Business Wire (Fri, 14-Nov 8:00 AM ET)
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath Lung Test Volume
Business Wire (Wed, 5-Nov 8:00 AM ET)
Business Wire (Tue, 28-Oct 8:00 AM ET)
bioAffinity Technologies Presents Research Supporting CyPath Lung Processing Methods at CHEST 2025
Business Wire (Mon, 20-Oct 8:00 AM ET)
Business Wire (Thu, 16-Oct 8:00 AM ET)
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
Business Wire (Wed, 15-Oct 8:00 AM ET)
Bioaffinity Technologies - Warrant trades on the stock market under the symbol BIAFW.
As of January 15, 2026, BIAFW stock price was flat at $0.34 with million shares trading.
BIAFW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, BIAFW traded as high as $2.90 and as low as $.05.
BIAFW has underperformed the market in the last year with a price return of -32.2% while the SPY ETF gained +20.2%. BIAFW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.0% and -2.9%, respectively, while the SPY returned +4.8% and +1.5%, respectively.
BIAFW support price is $.29 and resistance is $.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIAFW shares will trade within this expected range on the day.
